Why the study?
Are there differences between users of second and third generation oral contraceptives regarding the onset of thrombosis, and how do concurrent risk factors influence this?
Are there differences between users of second and third generation oral contraceptives regarding the onset of thrombosis, and how do concurrent risk factors influence this?
Women experiencing thrombosis on oral contraceptives have a notable prevalence of genetic thrombophilias, suggesting the need for screening in those with a family history of thrombosis.
No takes yet. Share an insight, caveat, or question.
This case series finds no timing differences by OC generation or genetic defects; hypothesis-generating for thrombophilia screening utility in family history-positive women.
Mira et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: